Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Boehringer Ingelheim

Status: Completed

Conditions: Hypertension

Treatments: Drug: Micardis

Study type: Observational

Funder types: Industry

Identifiers

NCT00879411

502.582

Details and patient eligibility

About

Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients

Enrollment: 670 patients

Sex: All

Ages: 18 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients who have recently been diagnosed with hypertension
2. Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.

Exclusion criteria

None (according to investigator)

Trial design

670 participants in 1 patient group

arterial hypertension

Treatment:

Drug: Micardis